ArticlePharmaceuticals (Basel, Switzerland)2019
Comparative Study of Two Oxidizing Agents, Chloramine T and Iodo-Gen
Article in Pharmaceuticals (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 21 citations in OpenAlex.
- EGFR- and Integrin αInternational journal of molecular sciences · 2024Review
- Assessment of bioactive peptides derived from laminin-111 as prospective breast cancer-targeting agents.Amino acids · 2024Article
- Radiosynthesis Standardization and Preclinical Assessment of the [Pharmaceuticals (Basel, Switzerland) · 2023Article
- Article
- Article
- Radiochemical and biological assessments of a PSMA-I&S cold kit for fast and inexpensiveFrontiers in chemistry · 2023Article
- Design and Characterization of Novel Antibody-Cytokine Fusion Proteins Based on Interleukin-21.Antibodies (Basel, Switzerland) · 2022Article
- Radioiodination and Purification of [Pharmaceuticals (Basel, Switzerland) · 2022Article
- Synthesis, stability, and cellular uptake ofHeliyon · 2021Article
- Standardization of the [Pharmaceuticals (Basel, Switzerland) · 2021Article
- Method development, validation, and impurity measurement of β-estradiol from radiolabeled [Journal of advanced pharmaceutical technology & researchArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parkinson's disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons in the
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.